Timothy Rothwell

Président chez EMISPHERE TECHNOLOGIES, INC.

Profil

Timothy G.
Rothwell is Chairman at Emisphere Technologies, Inc. since 2012, Chairman at Speracura LLC since 2009, and Chairman at PhageNova Bio, Inc. Former roles include President & Chief Executive Officer at Sanofi-Synthelabo, Inc. from 2003 to 2004, Chief Executive Officer at Sandoz Pharmaceuticals Corp., Chairman at Archimedes Pharma Ltd., Chairman at Sanofi-Aventis U.S.
LLC from 2007 to 2009, Chairman at New American Therapeutics, Inc., Independent Director at Agenus, Inc. in 2011, Director at Akrimax Pharmaceuticals LLC, Somerset Medical Center, Inc., Pharmaceutical Research & Manufacturers of America, National Academy of Medicine (United States), and CEO Roundtable on Cancer, Inc., Director at PheoPara Alliance from 2009 to 2013, Senior Vice President-Marketing & Sales at Squibb Corp., President-Global Prescription Business & EVP at Pharmacia Corp.
from 1998 to 2003, Trustee-Corporate Council at The Children's Health Fund, Trustee at HealthCare Institute of New Jersey, President-Global Pharmaceutical Operations at Rhone-Poulenc Rorer Pharmaceuticals, Inc. from 1995 to 1998, and Vice President-Global Marketing & Sales at Glaxo Wellcome, Inc. Education includes undergraduate studies at Drew University and graduate studies at Seton Hall University.

Postes actifs de Timothy Rothwell

Sociétés	Poste	Début
EMISPHERE TECHNOLOGIES, INC.	Président	18/09/2022
Speracura LLC	Président	01/01/2009
PhageNova Bio, Inc.	Président	-

Anciens postes connus de Timothy Rothwell

Sociétés	Poste	Fin
PheoPara Alliance	Président	-
AGENUS INC.	Directeur/Membre du Conseil	08/12/2011
Sanofi-Aventis U.S. LLC	Directeur Général	01/02/2007
Sanofi-Synthelabo, Inc.	Directeur Général	01/09/2004
Pharmacia Corp.	Corporate Officer/Principal	01/05/2003